echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Top of the list!

    Top of the list!

    • Last Update: 2022-01-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    *It is only for medical professionals to read for reference.
    The prevalence of diabetes in the elderly is high.
    Multidisciplinary experts come to cooperate!
    2021 is about to pass.
    Looking back on 2021, various industries have made some progress while responding to the epidemic

    .

    "Guidelines for Diagnosis and Treatment of Diabetes in the Elderly in China (2021 Edition)" was released in January 2021.
    Up to now, this guideline has the most read throughout the year (Most Read) among all academic papers, guidelines, and expert consensus published in Chinese Medical Journals in 2021.
    The top rankings and Most Download rankings are the "Guidelines for Diagnosis and Treatment of Diabetes in the Aged in China (2021 Edition)".
    Its cumulative readings and downloads have exceeded 120,000 times, and it has been widely praised by the industry

    .

    The prevalence of diabetes in the elderly is high, and there is an urgent need for clinical guidelines to standardize management.
    The epidemiological survey shows that the prevalence of diabetes in the elderly in China is about 30.
    2%, and the number of patients is 35.
    5 million, accounting for 1/4 of the global elderly diabetic patients.
    First in the world

    .

    It is worth noting that the rate of blood glucose control in elderly diabetic patients in China is only 43.
    4%, and 28.
    0% of elderly patients have a history of hypoglycemia

    .

    With the growing demand for diabetes management in the elderly in China, the management of elderly diabetic patients urgently needs to be standardized.
    Before 2021, there is no authoritative guideline for the management of elderly diabetes in this special population.
    Therefore, there is an urgent need to formulate guidelines for the elderly diabetic population in China.
    Corresponding clinical norms

    .

    The team of experts is strong, and multidisciplinary experts work together to cooperate.
    Diabetes and its complications and comorbidities are one of the important chronic diseases that affect the quality of life and life expectancy of the elderly

    .

    Senile diabetes has its own characteristics in terms of pathogenesis, clinical features, complications, and the occurrence of accompanying diseases
    .

    With the continuous accumulation of basic and clinical research in the field of senile diabetes, new therapeutic drugs, monitoring technologies, and new treatment concepts continue to emerge.
    There is an urgent need to formulate guidelines for standardized management of senile diabetes in China based on existing evidence

    .

    The National Center for Geriatrics, the Branch of Geriatrics of the Chinese Medical Association, and the Diabetes Professional Committee of the Chinese Geriatric Health Association organized more than 50 people from diabetes, endocrinology, geriatrics, neurology, nephrology, ophthalmology, rehabilitation medicine, and sports nutrition.
    Well-known domestic experts and scholars in many fields have worked together to jointly write the "Guidelines for Diagnosis and Treatment of Diabetes in the Elderly in China (2021 Edition)"

    .

    Professor Guo Lixin of the National Center for Geriatric Medicine of Beijing Hospital and Professor Xiao Xinhua of Peking Union Medical College Hospital are the co-corresponding authors of the guidelines
    .

    The guidelines were simultaneously published in the authoritative journals "Chinese Journal of Geriatrics" and "Chinese Journal of Diabetes" in January 2021
    .

    Emphasizes the comprehensive assessment and stratification of elderly diabetic patients, and proposes targeted management strategies.
    The "Guidelines for Diagnosis and Treatment of Diabetes in the Elderly in China (2021 Edition)" have been systematically searched to collect the latest high-level domestic and foreign research evidence related to elderly diabetes, especially a large number of high-level Quality Chinese evidence, detailed discussion of issues related to elderly diabetes, including the epidemiology of elderly diabetes and its complications, clinical features of elderly diabetes, comprehensive health assessment of elderly diabetic patients, blood glucose management, atherosclerotic heart The management of risk factors of vascular disease (arteriosclerotic cardiovascular disease, ASCVD), the management of acute and chronic complications, etc.
    , and the management of comorbid diseases and special circumstances in elderly diabetic patients were discussed in depth

    .

    In addition, the guidelines also emphasize that elderly diabetic patients are highly heterogeneous and need to adopt a stratified and highly individualized management strategy.
    It proposes a blood glucose management path suitable for elderly diabetes (including non-insulin treatment path and insulin treatment path) and a simple treatment concept.
    It also elaborated the "de-strengthening treatment strategy" proposed by the expert committee, emphasizing the need to balance the benefit-risk ratio of treatment, and the issuance of the guidelines is conducive to the "fine management" of elderly diabetes and the improvement of clinical outcomes

    .

    According to the characteristics of elderly diabetic patients, it is clear that the health status of the diagnosis and treatment path varies greatly among individuals, often accompanied by varying degrees of cognitive dysfunction and complex underlying diseases.
    Therefore, the "Guidelines for Diagnosis and Treatment of Diabetes in the Elderly (2021 Edition)" clearly point out that the elderly should be treated.
    Patients undergo a comprehensive evaluation, and a stratified and individualized management strategy is adopted based on the results of the evaluation

    .

    At the same time, the guidelines still propose the need to combine the particularities of elderly diabetic patients, including the high risk of hypoglycemia in elderly patients, poor cognitive function, high risk of malnutrition, many complications and comorbidities, increased postprandial blood glucose and multiple medications are common The priority is to choose hypoglycemic drugs with low risk of hypoglycemia, simplicity and high compliance, small impact on patients’ weight, no increase in the safety of patients’ important organs, effective reduction of postprandial blood glucose and low risk of drug interactions
    .

    For elderly diabetic patients who must be combined with insulin to control their blood sugar satisfactorily, the insulin regimen should be simplified as much as possible, emphasizing that the insulin treatment regimen needs to be "de-enhanced
    .
    "

    In addition, the guidelines also point out the need to pay attention to the management of comorbid diseases of diabetes in the elderly, and strengthen the screening and supportive treatment of comorbid diseases such as heart failure, osteoporosis, sarcopenia and frailty, falls, cognitive impairment and oral diseases in elderly patients
    .

    For special situations such as in-hospital management, home management and management of elderly care institutions for elderly diabetic patients, the guidelines also give corresponding guidelines for reference and reference by clinicians
    .

    The guidelines standardize the diagnosis and treatment of senile diabetes and contribute to a healthy China strategy.
    Based on the latest domestic and international clinical and scientific evidence, the guideline for the diagnosis and treatment of senile diabetes in China puts forward a new treatment concept and path for the diagnosis and treatment of senile diabetes based on the latest domestic and international clinical and scientific evidence.
    It is scientific, time-effective and operable.
    It is a programmatic document guiding the standardized diagnosis and treatment of senile diabetes in China at this stage

    .

    Once the guide was published, it attracted widespread attention and received wide acclaim in the industry
    .

    The issuance of the "Guide" can guide and help clinicians to carry out comprehensive and full-cycle standardized and comprehensive management of elderly diabetic patients, help improve the clinical outcomes of elderly diabetic patients, and contribute to the healthy China strategy
    .

    The series includes comprehensive evaluation of elderly diabetic patients, formulation of nutrition and exercise programs for elderly diabetic patients, how to follow the principles of drug therapy, how to correctly understand and rationally use recommended drugs at all levels, detailed explanations of insulin treatment pathways, and screening and evaluation of comorbid diseases of elderly diabetes.
    And management, etc.
    , come and get what you are interested in!
    I heard that you want to get the highlights of the "Guide" directly? This is for you to arrange! (The editorial board personally read the "Guidelines for Diagnosis and Treatment of Diabetes in the Elderly in China (2021 Edition)", and the lecture will start soon!) There is also the wonderful content of "Comprehensive Evaluation of Elderly Diabetes Patients" read by the editorial board of "Guidelines" (Indispensable! Treatment of elderly diabetes , Comprehensive assessment of health status first) Follow-up, you can also see "Preparation of nutrition and exercise programs for elderly diabetic patients", "How to follow the principles of drug treatment and medication", "Correctly understand and rationally use recommended drugs at all levels", "Detailed explanation of insulin therapy path", "Elderly Screening, Evaluation and Management of Diabetes Comorbidities" and so on, come and see what you are interested in! You can also scan the QR code below to move to the live broadcast room of the Doctor Station, and you can watch nearly ten members of the "Guide" editorial board read the "Guidelines for Diagnosis and Treatment of Diabetes in the Elderly in China (2021 Edition)"

    .

    This article is organizedThe editor in charge of the medical endocrinology channelCao Qian’s copyright statement
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.